Description
CNX-774 inhibits Bruton’s tyrosine kinase (BTK) and displays potential anticancer and immunosuppressive activities.
Product Unit Size | Cost | Quantity | Stock |
---|
CNX-774 inhibits Bruton’s tyrosine kinase (BTK) and displays potential anticancer and immunosuppressive activities.
Cas No. | 1202759-32-7 |
---|---|
Purity | ≥98% |
Formula | C26H22FN7O3 |
Formula Wt. | 499.50 |
Chemical Name | 4-[4-[[5-fluoro-4-[3-(prop-2-enoylamino)anilino]pyrimidin-2-yl]amino]phenoxy]-N-methylpyridine-2-carboxamide |
IUPAC Name | 4-[4-[[5-fluoro-4-[3-(prop-2-enoylamino)anilino]pyrimidin-2-yl]amino]phenoxy]-N-methylpyridine-2-carboxamide |
Synonym | CNX774 |
Solubility | DMSO 100 mg/mL (200.2 mM) Ethanol 2 mg/mL (4.0 mM) Water Insoluble |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Akinleye A, Chen Y, Mukhi N, et al. Ibrutinib and novel BTK inhibitors in clinical development. J Hematol Oncol. 2013 Aug 19;6:59. PMID: 23958373.
NO donor; annexin A2 inhibitor.
SIRT1/2 inhibitor, indirect p53 activator.
Neutrophil elastase inhibitor.
Non-depolarizing NMJ blocker; AChR antagonist.<...
Peptide, oxytocin analog; potential OXTR agonis...
Flavonoid found in Scutellaria; CDK9 inhibitor....
Immunodominant peptide epitope occurring in mul...
Antimicrobial peptide found in amphibians.
Endogenous cardiomodulatory peptide; NPR-B agon...
Selective HDAC4 and HDAC5 inhibitor.
EGFR (T790M) inhibitor.
JAK2 inhibitor.
Synthetic peptice; μOR agonist.
PKA inhibitor.
Prenylated phenolic terpene found in various pl...
V600E B-Raf inhibitor.
Catechol-type flavonoid; fatty acid synthesis i...
Fungal metabolite produced by Penicillium speci...
Endogenous neuropeptide involved in hormone rel...